Expected Moves

Estimated date for Q3 2026 financials. Agrios remains under a multi-year Cease Trade Order with OTC Expert Market designation, making compliant filings highly improbable.

Ongoing regulatory scrutiny over the company's lack of current information. Continued non-compliance risks permanent quotation removal or full deregistration.

Estimated timing for fiscal year-end 2026 disclosures. The absence of corporate communication suggests a continued state of dormancy.

Potential formal liquidation of legacy aeroponic properties or the corporate shell to satisfy historical debt obligations.